U.S. IT Stock News

EPAM Systems (NYSE:EPAM) has launched Empathy Lab by EPAM in North America to focus on AI native marketing and brand growth. The company has appointed industry veteran Ben Hall to lead the agency's expansion in the region. The move targets rising client demand for AI driven, orchestrated marketing solutions that connect technology and human centered design. EPAM Systems comes into this launch with a share price of $138.85 and multi year returns that have been under pressure, including a...

If you are looking at Cleveland-Cliffs and wondering whether the recent share price really reflects the value of the business, this article will walk through what the numbers are saying. The stock last closed at US$10.65, with returns of 2.6% over 7 days, a 29.4% decline over 30 days, and year to date and 1 year returns of 21.7% and 6.2% declines respectively, while the 3 year and 5 year returns are 46.0% and 20.2% declines. These moves sit against a broader backdrop of ongoing interest in...

How Marqeta’s Recent Performance Frames Today’s Investment Debate Marqeta (MQ) has seen mixed share performance, with a 2.4% gain over the past day and 8.2% over the past week, set against weaker returns over the past month and past 3 months. For investors, that contrast, alongside annual revenue of about US$588.6 million and a reported net loss of US$39.6 million, keeps the focus on how the company’s card issuing platform and growth in financial metrics might balance ongoing profitability...

Dover (DOV) has attracted fresh attention after recent trading left the stock at $233.31, with returns of 0.3% over the past day and 27.5% over the past 3 months catching investors’ eyes. See our latest analysis for Dover. Beyond the latest move, Dover’s momentum has been building, with a 12.9% 1 month share price return and multi year total shareholder returns above 60%, suggesting investors have been reassessing both growth potential and risks. If Dover’s climb has you thinking about where...

If you are wondering whether Whirlpool's current share price is giving you genuine value or just looks cheap at first glance, this article will walk through what the numbers are actually saying. Whirlpool shares most recently closed at US$84.49, with a 7 day return of a 4.7% decline, a 30 day return of a 1.1% decline, a year to date gain of 13.4%, and a 1 year return of a 14.3% decline, set against a 3 year return of a 27.0% decline and a 5 year return of a 43.3% decline. These mixed returns...

For readers wondering whether Keysight Technologies at around US$243 per share still offers value or if the easy money is already gone, this article will walk through what the current price might be implying. The stock has returned 4.3% over the last 7 days, 14.4% over the past month, 17.9% year to date and 38.8% over the past year, with longer term returns of 54.3% over 3 years and 72.1% over 5 years. Recent coverage has focused on Keysight's role in electronic design and test solutions, as...

XPeng (NYSE:XPEV) has launched a unified global in-app charging payment solution through a new partnership with Antom. The rollout begins outside mainland China with coverage in Hong Kong and planned expansion into Southeast Asia. The service enables cross-border, multi-currency payments for electric vehicle charging within XPeng's ecosystem. XPeng, an electric vehicle maker listed on the NYSE under ticker XPEV, is expanding its charging and software ecosystem as global EV adoption scales...

Natera recently attracted positive attention after Duquesne Family Office highlighted the company’s strong oncology testing momentum, including 54% growth in third-quarter oncology volumes and expanding use of its Signatera molecular residual disease blood test, which now represents nearly a quarter of total tests. While Natera remains unprofitable, its recurring revenue base, cash generation and scalable diagnostics platform across women’s health, oncology and organ health are drawing...

If you are wondering whether Doximity is starting to look like value or is still priced for high expectations, you are in the right place to assess what the current share price really reflects. The stock most recently closed at US$25.55, after a 2.1% move over the past week, but with much steeper returns of a 37.1% decline over 30 days, a 41.0% decline year to date, and a 64.7% decline over the past year. These sharp price moves have come alongside ongoing discussion about Doximity's role as...

If you are wondering whether Scholar Rock Holding's recent share price puts it on sale or already prices in a lot of optimism, you are asking the right question for a valuation focused look at the stock. The shares recently closed at US$48.00, with returns of 4.4% over 7 days, 8.4% over 30 days, 12.1% year to date, 27.3% over 1 year, a very large gain over 3 years, and a 11.3% decline over 5 years. This naturally raises questions about how much upside or risk is now built into the...

BioLife Solutions (BLFS) shares are in focus after the company entered a multi year supply agreement with Qkine Limited. The deal secures exclusive worldwide distribution rights to selected cytokine and growth factor products for cell and gene therapy manufacturing. See our latest analysis for BioLife Solutions. Despite the Qkine agreement, BioLife Solutions’ share price return has been mixed, with a 7 day gain of 3.87% but a 30 day and year to date share price decline. The 1 year total...

Earlier this week, UBS upgraded BlackRock to Buy after the asset manager reported strong fourth‑quarter results and highlighted a solid start to first‑quarter fund flows at the UBS Financials conference. This shift in analyst stance comes even as BlackRock manages headwinds such as outflows from its Bitcoin ETFs and concerns around private market liquidity, underlining how its broader business mix is shaping perceptions. We’ll now examine how UBS’s more positive view on BlackRock’s earnings...

Taylor Morrison Home recently launched its “Homes Built for Real Life” brand platform, highlighting authentic everyday living, while also reporting full-year 2025 revenue of US$8,121.48 million and net income of US$782.5 million, alongside a larger, extended share repurchase authorization through 2027. The combination of a consumer research-driven brand aimed at millennial and Gen Z buyers and an upsized US$1,000 million buyback plan underscores how Taylor Morrison is aligning its marketing,...

Why EVERTEC Just Caught Investor Attention EVERTEC (EVTC) is back on watch after a recent move in the share price, with the stock up 1.6% on the day and 4.5% over the past week despite weaker year and multi year returns. See our latest analysis for EVERTEC. The recent 1 day share price return of 1.62% and 7 day gain of 4.48% stand in contrast to a 30 day share price return of 7.55% and a 1 year total shareholder return of 16.53%. This points to short term momentum building after a weaker...

Wondering if Lockheed Martin's current share price reflects its true worth, or if the market is getting ahead of itself? This article is going to walk you through what the numbers actually say about value. Lockheed Martin closed at US$658.26 recently, with returns of 0.9% over 7 days, 11.4% over 30 days, 32.4% year to date and 53.8% over the past year. These figures have many investors asking whether the stock's risk and reward are still in balance. Recent headlines have focused on Lockheed...

What recent performance says about Herbalife stock Herbalife (HLF) has drawn fresh attention after a strong run, with the share price at $19.96 and total return figures of 20% over the past month and 67% over the past 3 months. For longer term holders, the stock shows a 56% decline over 5 years, alongside a 140% total return over the past year and a modest 2% total return over 3 years. This highlights mixed holding period experiences. See our latest analysis for Herbalife. The recent surge in...

Why Abbott Laboratories (ABT) is Back on Investors’ Radar Abbott Laboratories (ABT) is drawing fresh attention after recent share price moves, with the stock roughly flat over the past week but showing a gain over the past month and weaker returns over the past year. See our latest analysis for Abbott Laboratories. At a share price of US$112.21, Abbott’s recent 4.46% 1 month share price return contrasts with its weaker year to date share price performance and a 15.27% 1 year total shareholder...

If you are looking at AMETEK and wondering whether the current price really reflects its underlying worth, you are not alone. The stock last closed at US$233.51, with returns of 1.6% over 7 days, 5.8% over 30 days, 11.7% year to date, 26.3% over 1 year, 69.0% over 3 years, and 104.5% over 5 years. This naturally raises questions about how much future potential or risk is already priced in. Recent coverage around AMETEK has focused on its role in the capital goods space and how investors are...

What recent performance data suggests about Vistra Vistra (VST) has drawn attention after a period where the share price showed a small 1 day decline and was broadly flat over the past week, while still positive over the past month. For longer term holders, the stock shows a small decline over the past 3 months, set against a positive year to date move and a double digit total return over the past year, with even higher total returns over 3 and 5 years. Against this backdrop, you might be...

Recent performance snapshot and business overview Novo Nordisk (NYSE:NVO) has drawn investor attention after a one month return showing a 24% decline and a past three month gain of 5%, against a one year total return showing a 45% decline. The Denmark based pharmaceutical group reports annual revenue of DKK 309,064.0 and net income of DKK 102,434.0, with both revenue and net income growth stated at about 4%, anchored by its obesity, diabetes care, and rare disease segments. See our latest...

Targa Resources Corp. recently reported 2025 results showing revenue of US$17.03 billion and net income of US$1.92 billion, while also outlining extensive new gas processing and NGL infrastructure projects across the Permian and Gulf Coast that are scheduled to come online through 2028. The company coupled this with a planned 25% increase in its 2026 annual common dividend per share to US$5.00, underpinned by record volumes, expanding processing and fractionation capacity, and ongoing share...

Pool (POOL) has attracted investor attention after recent share price moves, with the stock showing a 1 day gain of 1.49% but negative returns over the past week and month. See our latest analysis for Pool. That 1 day share price gain sits against weaker momentum, with a 7 day share price return of 16.63% and a 30 day share price return of 16.38%. The 1 year total shareholder return of 34.66% and 5 year total shareholder return of 29.70% point to sustained pressure rather than a recent...

Henry Schein One recently announced a direct data integration between Align Technology’s iTero intraoral scanners and its Dentrix, Dentrix Ascend, and Dentally practice management platforms, allowing automatic import of scans into patient records and reducing manual workflows for dental practices across multiple regions. This integration deepens iTero’s role at the center of digital practice workflows, potentially making Invisalign-linked scanning more embedded in everyday clinical and...

General Motors (GM) has put fresh capital behind its long game in trucks and SUVs, outlining nearly US$1.8b for a next generation small block V8, along with more than US$63m for its Oshawa Assembly plant. See our latest analysis for General Motors. Those new truck and SUV investments sit against a share price of US$81.51, with a 90 day share price return of 14.8% and a 1 year total shareholder return of 77.9%. This suggests momentum has been building as GM balances recalls, inventory...